InBios International, Inc.

InBios International, Inc. — FDA 510(k) Submissions

InBios International, Inc. has submitted 7 FDA 510(k) premarket notifications since 2014, of which 5 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Zika Virus Serological Reagents, Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples, Leishmania Spp. Antigen Detection Assay, Enzyme Linked Immunosorbent Assay, T. Cruzi, Dengue Virus Antigen Assay . Use the specialty filter in the sidebar to narrow results.